Association between ginseng intake and mortality: Kangwha cohort study

Journal of Alternative and Complementary Medicine

Volumn 15, Issue 8, 2009, Pages 921-928

  Yi, Sang Wook ^a   Sull, Jae Woong ^b   Hong, Jae Seok ^c   Linton, John Alderman ^d   Ohrr, Heechoul ^b  

^a Catholic Kwandong University   (South Korea)

^b Yonsei University   (South Korea)

^c Health Insurance Review Agency   (South Korea)

^d Yonsei University College of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

GINSENG EXTRACT;

ADULT; ARTICLE; CANCER MORTALITY; CARDIOVASCULAR DISEASE; CAUSE OF DEATH; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; GENDER; GINSENG; HUMAN; KOREA; MAJOR CLINICAL STUDY; MALE; MORTALITY; NONHUMAN; PRIORITY JOURNAL;

AGED; CARDIOVASCULAR DISEASES; CAUSE OF DEATH; COHORT STUDIES; FEMALE; HUMANS; KOREA; LONGEVITY; MALE; MIDDLE AGED; MORTALITY; MULTIVARIATE ANALYSIS; NEOPLASMS; PANAX; PLANT EXTRACTS; PROPORTIONAL HAZARDS MODELS; SEX FACTORS; SURVIVAL ANALYSIS;

EID: 70350099283     PISSN: 10755535     EISSN: None     Source Type: Journal    
DOI: 10.1089/acm.2008.0296     Document Type: Article

References (28)

1. Yun TK. Panax ginseng: A non-organ-specific cancer preventive? Lancet Oncol 2001;2:49-55.
2. Siegel RK. Ginseng abuse syndrome. Problems with the panacea. JAMA 1979;241:1614-1615.
3. Blumenthal M, Cavaliere C, Rea P. Herbal supplement sales in United States show growth in all channels. HerbalGram 2008;78:60-63.
4. Coon JT, Ernst E. Panax ginseng: A systematic review of adverse effects and drug interactions. Drug Saf 2002;25:323-344.
5. Shin HR, Kim JY, Yun TK, et al. The cancer-preventive potential of Panax ginseng: A review of human and experimental evidence. Cancer Causes Control 2000;11:565-576.
6. Yun TK, Choi SY. A case-control study of ginseng intake and cancer. Int J Epidemiol 1990;19:871-876.
7. Yun TK, Choi SY. Preventive effect of ginseng intake against various human cancers: A case-control study on 1987 pairs. Cancer Epidemiol Biomarkers Prev 1995;4:401-408.
8. Yun TK, Choi SY. Non-organ specific cancer prevention of ginseng: A prospective study in Korea. Int J Epidemiol 1998; 27:359-364.
9. Cui Y, Shu XO, Gao YT, Cai H, Tao MH, Zheng W. Association of ginseng use with survival and quality of life among breast cancer patients. Am J Epidemiol 2006;163:645-653.
10. Kamangar F, Gao YT, Shu XO, et al. Ginseng intake and gastric cancer risk in the Shanghai Women's Health Study cohort. Cancer Epidemiol Biomarkers Prev 2007;16:629-630.
11. Yang S, trans. The Divine Farmer's Materia Medica: A Translation of the Shen Nong Ben Cao Jing. Boulder: Blue Poppy Press, 1998.
12. Hong JS, Yi SW, Kang HC, et al. Age at menopause and cause-specific mortality in South Korean women: Kangwha Cohort Study. Maturitas 2007;56:411-419.
13. Hong JS, Yi SW, Kang HC, Ohrr H. Body mass index and mortality due to cardiovascular disease in South Korean men: Kangwha Cohort Study. Ann Epidemiol 2007;17:622-627.
14. Ohrr H, Yi SW, Sull JW, Hong JS. Korea, Kangwha County. In: Parkin DM, Whelan SL, Ferlay LT, Thomas DB, eds. Cancer Incidence in Five Continents, vol.VIII. Lyon, France: International Agency for Research on Cancer (IARC), 2002. (IARC Scientific Publications No. 155).
15. Allison PD. Survival Analysis Using the SAS System: A Practical Guide. Cary, NC: SAS Institute, 1995.
16. Eisenberg DM, Davis RB, Ettner SL, et al. Trends in alternative medicine use in the United States, 1990-1997: Results of a follow-up national survey. JAMA 1998;280:1569-1575.
17. Nilsson M, Trehn G, Asplund K. Use of complementary and alternative medicine remedies in Sweden. A population-based longitudinal study within the northern Sweden MONICA project. Multinational Monitoring of Trends and Determinants of Cardiovascular Disease. J Intern Med 2001;250: 225-233.
18. Ernst E, White A. The BBC survey of complementary medicine use in the UK. Complement Ther Med 2000;8:32-36.
19. 19. Ernst E. The risk-benefit profile of commonly used herbal therapies: Ginkgo, St. John's Wort, Ginseng, Echinacea, Saw Palmetto, and Kava. Ann Intern Med 2002;136:42-53. Erratum in: Ann Intern Med 2003;138:79.
20. Kitts D, Hu C. Efficacy and safety of ginseng. Public Health Nutr 2000;3:473-485.
21. Buettner C, Yeh GY, Phillips RS, et al. Systematic review of the effects of ginseng on cardiovascular risk factors. Ann Pharmacother 2006;40:83-95.
22. Buettner C, Phillips RS, Davis RB, et al. Use of dietary supplements among United States adults with coronary artery disease and atherosclerotic risks. Am J Cardiol 2007;99:661-666.
23. Kitts D, Hu C. Efficacy and safety of ginseng. Public Health Nutr 2000;3:473-485.
24. Liu Y, Ma H, Zhang JW, et al. Influence of ginsenoside Rh1 and F1 on human cytochrome p450 enzymes. Planta Med 2006;72:126-131.
25. He N, Edeki T. The inhibitory effects of herbal components on CYP2C9 and CYP3A4 catalytic activities in human liver microsomes. Am J Ther 2004;11:206-212.
26. Finnstrom N, Ask B, Dahl ML, Rane A. Intra-individual variation and sex differences in gene expression of cytochromes P450 in circulating leukocytes. Pharmacogenomics J 2002;2: 111-116.
27. Yun TK. Experimental and epidemiological evidence on non-organ specific cancer preventive effect of Korean ginseng and identification of active compounds. Mutat Res 2003;523-524:63-74.
28. Goodman SN. Toward evidence-based medical statistics. 2: The Bayes factor. Ann Intern Med 1999;130:1005-1013.